
Loading, please wait...

Loading, please wait...

The Expert Panel for Cosmetic Ingredient Safety (Panel) recently released findings regarding cosmetic starch phosphates safety. This comprehensive report evaluated four specific ingredients commonly found in personal care products. These substances include Distarch Phosphate, Distarch Phosphate Acetate, Hydroxypropyl Starch Phosphate, and Sodium Hydroxypropyl Starch Phosphate. Currently, Distarch Phosphate serves as an essential anticaking agent and binder in many formulations. Meanwhile, manufacturers use the other three ingredients primarily to increase product viscosity and improve texture. The Panel concluded that these modified starches are safe under current concentrations and practices.
The safety assessment primarily focused on the chemical structures and biological interactions of these ingredients. Consequently, researchers discovered that the large molecular sizes of these starches effectively prevent significant skin penetration. This physical property minimizes systemic risks for consumers during topical application. Furthermore, clinical data shows that these ingredients are non-irritating and non-sensitizing for most skin types. Since regulatory bodies already approve these modified starches for food use, their topical safety profile remains exceptionally high for the general population.
Clinicians frequently encounter these ingredients in common items like moisturizers, foundations, and hair sprays. For instance, Hydroxypropyl Starch Phosphate currently appears in over 260 unique cosmetic formulations. Although some animal studies showed mild ocular irritation, these effects resolved quickly within 72 hours without permanent damage. Therefore, doctors can confidently reassure patients that these starches pose no significant health risk when used as directed in cosmetics. These findings support the continued use of starch-based alternatives in the growing clean-label personal care market.
You can find these ingredients in moisturizers, foundations, hair sprays, and sunscreens, where they act as thickeners, binders, or oil-absorbents.
Yes, clinical data indicates they are non-sensitizing and generally non-irritating, making them suitable for most skin types including sensitive skin.
No, their large molecular structure prevents them from penetrating the skin barrier, which significantly limits systemic exposure and toxicity risk.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Johnson W et al. Safety Assessment of Starch Phosphates as Used in Cosmetics. Int J Toxicol. 2026 Feb 28. doi: 10.1177/10915818261425590. PMID: 41761848.
2. Cosmetic Ingredient Review (CIR) Expert Panel. Safety Assessment of Starch Phosphates as Used in Cosmetics. 2022. Available from cir-safety.org.
3. SpecialChem. Hydroxypropyl Starch Phosphate Safety Profile and Cosmetic Functions. 2023. Available from specialchem.com.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Expert Panel for Cosmetic Ingredient Safety confirms that starch phosphates are safe for use in cosmetics as binders and viscosity agents....
7 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today